Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
NCT00399464
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1177
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
alfuzosin
Sponsor
Sanofi